Advyzon Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.37M Buy
3,774
+380
+11% +$130K 0.1% 198
2026
Q1
$1.19M Buy
3,394
+91
+3% +$32.4K 0.11% 187
2025
Q4
$1.08M Buy
3,303
+2,097
+174% +$665K 0.13% 181
2025
Q3
$340K Buy
+1,206
New +$350K 0.06% 301
2025
Q2
– Sell
-712
Closed -$222K – 383
2025
Q1
$222K Sell
712
-177
-20% -$52.3K 0.08% 233
2024
Q4
$232K Buy
+889
New +$264K 0.09% 204

Other funds holding AMGN

Advyzon Investment Management's AMGN Position: Q2 2026 in Review

Advyzon Investment Management increased its Amgen (AMGN) stake by 11% in Q2 2026, buying an estimated $130K and bringing the position to 3,774 shares worth $1.37M. The position accounts for 0.1% of the portfolio, ranked #198.

Advyzon Investment Management first reported a position in AMGN in Q4 2024 and has held it in 6 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Advyzon Investment Management held 3,774 shares of Amgen worth $1.37M as of Q2 2026.
  • Advyzon Investment Management bought 380 Amgen shares in Q2 2026, an estimated $130K.
  • Amgen made up 0.1% of Advyzon Investment Management's portfolio in Q2 2026, its #198 holding.
  • Advyzon Investment Management first reported a position in Amgen in Q4 2024 and has held it in 6 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Advyzon Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.